Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Curcumin Enhances the Sensitivity of Bortezomib By Inhibiting NF-Κb in ABC Diffuse Large B-Cell Lymphoma Cells

Xiaolei Wei, PhD, Jialin Song, Yongqiang Wei, PhD, Hong Zeng, Weimin Huang, PhD, Jingxia Zheng, Ru Feng, MD

Blood (2019) 134 (Supplement_1): 5237.

https://doi.org/10.1182/blood-2019-127705

Published: 2019

Journal Articles

Non-Hematologic Therapy Toxicities Correlated with Survival, Drug Discontinuation and Response in Multiple Myeloma Patients: A Retrospective Study

Weimin Huang, PhD, Yongqiang Wei, PhD, Jingxia Zheng, Xiaolei Wei, PhD, Ru Feng, MD

Blood (2019) 134 (Supplement_1): 5496.

https://doi.org/10.1182/blood-2019-126751

Published: 2019

Journal Articles

The Efficacy and Safety of Cidofovir in Salvage Therapy for CMV Infection in the Patients with Haploid Hematopoietic Stem Cell Transplantation

Guo-Pan Yu, MD, Zhao Yin, Zhiping Fan, Fen Huang, Na Xu, Ling Jiang, Zhixiang Wang, PhD, Li Xuan, MD, Qifa Liu, MD, Ru Feng, MD, Jing Sun

Blood (2019) 134 (Supplement_1): 5659.

https://doi.org/10.1182/blood-2019-126705

Published: 2019

Journal Articles

HIF-1a Regulating the Chemoresistance By Upregulating the Expression of xCT and GCLM in the Diffuse Large B Cell Lymphoma

Yongqiang Wei, PhD, Hong Zeng, Xiaolei Wei, PhD, Weimin Huang, PhD, Jialin Song, Jingxia Zheng, Ru Feng, MD

Blood (2019) 134 (Supplement_1): 5236.

https://doi.org/10.1182/blood-2019-127612

Published: 2019

Journal Articles

Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

Blood (2018) 132 (Supplement 1): 148.

https://doi.org/10.1182/blood-2018-99-117956

Published: 2018

Journal Articles

PKM2 Expression Is Associated with Favorable Outcome in Patients with Diffuse Large B-Cell Lymphoma

Yongqiang Wei, MD, Xiaolei Wei, Jialin Song, Weimin Huang, Hong Zeng, Jingxia Zheng, Qi Wei, Ru Feng, MD

Blood (2018) 132 (Supplement 1): 5319.

https://doi.org/10.1182/blood-2018-99-112849

Published: 2018

Journal Articles

Disulfram/Copper Complex May Enhance Its Cytotoxic Effect on CD34+CD38- KG1-Alpha Cells By Down Regulating the Expression of HIF1-Alpha in the Co-Cultured MSCs

Guo Xutao, PhD, Haiqing Zheng, Shi Pengcheng, Wang Yan, Liang Jiabao, Ru Feng, MD, Bing Xu, MD PhD

Blood (2018) 132 (Supplement 1): 5143.

https://doi.org/10.1182/blood-2018-99-112136

Published: 2018

Journal Articles

Albumin Improves Stratification in the Low IPI Risk Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Yongqiang Wei, MD, Weimin Huang, Jialin Song, Hong Zeng, Jingxia Zheng, Qi Wei, Ru Feng, MD

Blood (2018) 132 (Supplement 1): 5412.

https://doi.org/10.1182/blood-2018-99-112824

Published: 2018

Journal Articles

Influence of FLT3 -ITD Mutation and Length on the Treatment Response and Prognosis in Cytogenetically Normal AML Patients

Xuejie Jiang, MD, Changxin Yin, Junya Sun, Jiaying Cheng, Qiang Wang, Guopan Yu, Ling Jiang, Dan Xu, Xiaoli Liu, Ru Feng, MD, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 5245.

https://doi.org/10.1182/blood-2018-99-111063

Published: 2018

Journal Articles

Varicella Zoster Virus Reactivation Can be Prevented Very Well By Valacyclovir in Patients with Multiple Myeloma Treated with Bortezomib

Qi Wei, Yongqiang Wei, MD, Ru Feng, MD, Xiaolei Wei

Blood (2018) 132 (Supplement 1): 5655.

https://doi.org/10.1182/blood-2018-99-113369

Published: 2018

Journal Articles

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

Blood (2017) 130 (Supplement 1): 5167.

https://doi.org/10.1182/blood.V130.Suppl_1.5167.5167

Published: 2017

Journal Articles

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Blood (2017) 130 (Supplement 1): 5213.

https://doi.org/10.1182/blood.V130.Suppl_1.5213.5213

Published: 2017

Journal Articles

Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 5208.

https://doi.org/10.1182/blood.V130.Suppl_1.5208.5208

Published: 2017

Journal Articles

A Story about a Mother with Chronic Lymphocytic Leukemia after Chronic Phase of Chronic Myeloid Leukemia and Her Daughter with Chronic Myeloid Leukemia: Case Report and Literature Review

Qi Wei, MD, Yongqiang Wei, MD, Xiaolei Wei, Xiaofang LI, MD, Hui Liu, MD, Ru Feng, MD

Blood (2017) 130 (Supplement 1): 5265.

https://doi.org/10.1182/blood.V130.Suppl_1.5265.5265

Published: 2017

Journal Articles

Beta-2 Microglobulin Improves the IPI Risk Stratification in Patients with Diffuse Large B-Cell Lymphoma

Yongqiang Wei, MD, Xiaolei Wei, Weimin Huang, Jialin Song, Qi Wei, MD, Ru Feng, MD

Blood (2017) 130 (Supplement 1): 5233.

https://doi.org/10.1182/blood.V130.Suppl_1.5233.5233

Published: 2017

Journal Articles

Low Serum Albumin Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Yongqiang Wei, MD, Weimin Huang, Jialin Song, Qi Wei, MD, Ru Feng, MD

Blood (2017) 130 (Supplement 1): 5237.

https://doi.org/10.1182/blood.V130.Suppl_1.5237.5237

Published: 2017

Journal Articles

Detection of miR3151 Gene Expression in De Novo Adult Acute Myeloid Leukemia and Its Clinical Implication

Guo Xutao, PhD, Yan Wang, Pengcheng Shi, Suqi Deng, Haiqing Zheng, Ru Feng, MD, Bing Xu, MD PhD

Blood (2017) 130 (Supplement 1): 5076.

https://doi.org/10.1182/blood.V130.Suppl_1.5076.5076

Published: 2017

Journal Articles

Apoptotic Osteocytes Promote Myeloma Dissemination to New Bone Sites Via Suppression of Immune Surveillance in Bone Marrow

Xiaoxiao Hao, Ru Feng, MD, Timothy Trotter, Pramod Gowda, Mary Fok, Xiaoxuan Xu, Denise Peker, MD, Amjad Javed, Yang Yang, MD

Blood (2017) 130 (Supplement 1): 125.

https://doi.org/10.1182/blood.V130.Suppl_1.125.125

Published: 2017

Journal Articles

NCCN-IPI Is Superior to aaIPI and IPI in Predicting Survival of DLBCL in the Rituximab Era

Yongqiang Wei, Yuankun Zhang, Xiaoxiao Hao, Xiaolei Wei, Weimin Huang, Ru Feng, MD

Blood (2016) 128 (22): 1872.

https://doi.org/10.1182/blood.V128.22.1872.1872

Published: 2016

Journal Articles

Influence of Biological Character of Acute Lymphoblastic Leukemia Cell Linet after Overexpression of C/EBPa and PU.1

Linwei Xu, Xiaoxiao Hao, Yongqiang Wei, Xiaolei Wei, Qi Wei, Ru Feng, MD

Blood (2016) 128 (22): 5060.

https://doi.org/10.1182/blood.V128.22.5060.5060

Published: 2016

NARROW

Curcumin Enhances the Sensitivity of Bortezomib By Inhibiting NF-Κb in ABC Diffuse Large B-Cell Lymphoma Cells

Non-Hematologic Therapy Toxicities Correlated with Survival, Drug Discontinuation and Response in Multiple Myeloma Patients: A Retrospective Study

The Efficacy and Safety of Cidofovir in Salvage Therapy for CMV Infection in the Patients with Haploid Hematopoietic Stem Cell Transplantation

HIF-1a Regulating the Chemoresistance By Upregulating the Expression of xCT and GCLM in the Diffuse Large B Cell Lymphoma

Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

PKM2 Expression Is Associated with Favorable Outcome in Patients with Diffuse Large B-Cell Lymphoma

Disulfram/Copper Complex May Enhance Its Cytotoxic Effect on CD34+CD38- KG1-Alpha Cells By Down Regulating the Expression of HIF1-Alpha in the Co-Cultured MSCs

Albumin Improves Stratification in the Low IPI Risk Patients with Diffuse Large B-Cell Lymphoma

Influence of FLT3 -ITD Mutation and Length on the Treatment Response and Prognosis in Cytogenetically Normal AML Patients

Varicella Zoster Virus Reactivation Can be Prevented Very Well By Valacyclovir in Patients with Multiple Myeloma Treated with Bortezomib

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma

A Story about a Mother with Chronic Lymphocytic Leukemia after Chronic Phase of Chronic Myeloid Leukemia and Her Daughter with Chronic Myeloid Leukemia: Case Report and Literature Review

Beta-2 Microglobulin Improves the IPI Risk Stratification in Patients with Diffuse Large B-Cell Lymphoma

Low Serum Albumin Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma

Detection of miR3151 Gene Expression in De Novo Adult Acute Myeloid Leukemia and Its Clinical Implication

Apoptotic Osteocytes Promote Myeloma Dissemination to New Bone Sites Via Suppression of Immune Surveillance in Bone Marrow

NCCN-IPI Is Superior to aaIPI and IPI in Predicting Survival of DLBCL in the Rituximab Era

Influence of Biological Character of Acute Lymphoblastic Leukemia Cell Linet after Overexpression of C/EBPa and PU.1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only